SavedAdd your journal

Journals / The European Research Journal / 2019 / Cilt: 5 - Sayı: 1

Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis

Hilmi Erdem SÜMBÜL
Onur TAKTAKOĞLU
Pages
233–235
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

No abstract available.

🔖

Cite This Article

SÜMBÜL, H. E., TAKTAKOĞLU, O. (2019). Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. The European Research Journal, Cilt: 5 - Sayı: 1, 233–235. https://ajindex.com/articles/361255

References (5)

  1. George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010. Blood 2010;116:4060-9
  2. Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patient with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-11
  3. George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 2006;21:49-56
  4. Ling HT, Field JJ, Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol 2009;84:418-21
  5. McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmakonetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010;8:1201-8.